Antonio Gallardo-Pizarro retweeted
🆕💥🔴Case series
Successful management of histoplasmosis with "novel" triazole antifungals(posaconazole and isavuconazole) #IDXposts academic.oup.com/jac/article…
Antonio Gallardo-Pizarro retweeted
In 1992 Peter Ratcliffe received this rejection from Nature.
Almost 30 years later he won the Nobel Prize for the same discovery.
Don't lose faith in the things you believe in.
Antonio Gallardo-Pizarro retweeted
Emotivo acto de conmemoración del 50 aniversario del Programa de #TPH del @hematoclinicbcn, bajo la actual dirección de la presidenta de @GETH_info. Una huella indeleble en pacientes, profesionales y el resto del ecosistema #TerCel de nuestro país. ¡Enhorabuena!
Antonio Gallardo-Pizarro retweeted
Oral poster; excellent work & presentation! Neutropenic patients with fever needs a personalized antibiotic approach based on machine learning and prior colonization
#ProudOfMyTeam
#ESCMIDGlobal2026
@hospitalclinic @escmid
📢Recordamos, V Reunión científica anual de GESITRA-IC @GesitraIC, @SEIMC_
📅 5-6 de marzo
📍Madrid
📚📝Programa/inscripción 👇
seimc.org/grupos-de-estudio/…
Antonio Gallardo-Pizarro retweeted
Febrile neutropenia still drives heavy carbapenem use due to MDR Gram-negatives. In a cohort of 553 FN episodes, an ML risk model + prior colonisation data could cut meropenem use by ~30% and IEAT from 23% to 9%, supporting personalised EAT.
journals.sagepub.com/doi/ful…
Antonio Gallardo-Pizarro retweeted
Based on expert opinion, national guidelines suggest obtaining 2 sets of blood cultures at the onset of FN and repeating cultures on FN days 2-3.
🆕⚡Retrospective cohort study of patients with hem/onc diagnoses & an FN episode >3d
Detection of new BSI after FN day 3 was uncommon, demonstrating low diagnostic yield of repeat blood cultures after FN day 3.
In a cohort of >500 patients with persistent FN, new BSI after FN day 3 was identified in 4% of patients and 2% of days with cultures collected. FN onset in the peri-HCT period (day -7 to +30) was associated with 80% lower odds of new BSI after FN day 3. Among new organisms in blood cultures after FN day 3, 26% were contaminants with over half leading to excess vancomycin use, highlighting the importance of diagnostic stewardship in this population.
@BradSpellberg @DrToddLee ICYMI #IDXposts academic.oup.com/cid/article…
Antonio Gallardo-Pizarro retweeted
💥#ProudOfMyTeam
🎯New accepted paper!
Impact of Novel β-Lactams on Gut Decolonisation in Haematological Patients with Multidrug-Resistant Gram-Negative Infections
@sehh_es @SEIMC_ @ESCMID @EHA_Hematology @TheEBMT @hospitalclinic @idibaps
sciencedirect.com/science/ar…
Antonio Gallardo-Pizarro retweeted
💥#ProudOfMyTeam
New accepted paper!
Congrats @agallardop_ !
Proof of concept: #AI and rectal swabs improves empiric antibiotic selection in febrile neutropenia!!
pmc.ncbi.nlm.nih.gov/article…
@sehh_es @SEIMC_ @ESCMID @EHA_Hematology @TheEBMT @hospitalclinic @idibaps @CoREIMC_seimc
Antonio Gallardo-Pizarro retweeted
Tratamiento ambulatorio en pacientes con endocarditis infecciosa: análisis de las estrategias actuales. Marta Maristany @hospitalclinic en #SEICAV25 @IETeamClinicBCN #endocarditis
Antonio Gallardo-Pizarro retweeted
Gene therapy has long held promise for the treatment of Parkinson’s disease.
In @TheLancetNeuro, authors explore clinical trials and technical advances in gene therapy for Parkinson's disease: hubs.li/Q03zZPW-0
Antonio Gallardo-Pizarro retweeted
A brilliant UCLA Hematologist, Dr. Gary Schiller, said something to me when I was a medical student that I didn't understand at the time, but in retrospect, turns out to have had a profound, long-lasting impact on me. Specifically, on how I view the concept of "expertise".
Antonio Gallardo-Pizarro retweeted
#ProudOfMyTeam
💡📡News published in CMI!! 🔝🔝
Improving knowledge to personalize empiric antibiotic treatments in hematological patients
Congrats @agallardop_
Rectal colonization by MDR GNB and subsequent BSI in haematological patients pubmed.ncbi.nlm.nih.gov/4048…
Antonio Gallardo-Pizarro retweeted
#JornadaHematoAvanza25 👉 El trasplante de médula ósea es la #terapia celular más antigua que existe, y con ella se han curado miles de personas. Para ello, es fundamental la #donacion.
📹Te lo explica en este video Montserrat Rovira, del @hospitalclinic y si quieres saber➕, no te pierdas su ponencia completa en nuestro canal de #HemoTube 👉Más allá del cáncer sanguíneo youtube.com/watch?v=fMFaXQmp…
#HematoAvanza #HematoEnRed #THP #donamedula
Antonio Gallardo-Pizarro retweeted
Words matter.
It’s time to retire the term oral “step-down.”
It implies inferiority of the oral route—and doesn’t align with stewardship principles.
Terms like IV to oral switch or oral transition better promote optimal antimicrobial stewardship.
What terms do you use—and why?
Antonio Gallardo-Pizarro retweeted
Replying to @hospitalclinic @idibaps @jmcampis @CaixaResearchCA @FundlaCaixaCAT @UrbanoIspizuaMD @Manel_JuanOtero @salutcat @SaludISCIII @immunoclinicbcn @hematoclinicbcn
🏥 El #CLÍNIC-@idibaps ha alcanzado un hito histórico con el tratamiento de más de 5️⃣0️⃣0️⃣ pacientes con terapias CAR-T propias.
🧬 Es el único hospital de Europa que ha desarrollado íntegramente dos terapias CAR-T académicas que están aprobadas por una agencia reguladora (AEMPS).
🔬 En la actualidad se están desarrollando nuevos CAR-T para tratar a pacientes con diferentes tipos de tumores sólidos o enfermedades hematológicas. La investigación se centra también en mejorar la funcionalidad de los CAR-T una vez llegan al tumor.
👉 f.mtr.cool/tvxpmtbipi
Antonio Gallardo-Pizarro retweeted
Qué es el SITRAME? Nuevo síndrome autoinflamatorio descrito en adultos. Atentos a las características: semejan celulitis recurrentes sobre todo en tronco con fiebre
#SCAEDV #Dermatologia
Ya no se trata solo de elegir el antibiótico.
En neutropenia febril, el cambio es de estrategia.
IA y decisiones que importan.
Nos vemos en Cartagena! 🦾 @Area2Cartagena
XXIV Jornadas sobre Actualización en Enfermedades Infecciosas: IA y E. infecciosas
📅26 y 27 de marzo de 2025
📍Murcia
📚📝Ampliar detalles (programa, inscripción) consultando el enlace👇
seimc.org/formacion-continua…
1
830































